France to Beef Up Clinical Trial Requirements for Flow Diverter Stents

The GMP Letter
A A
France’s National Agency for the Safety of Medicines (ANSM) is calling for more exhaustive clinical studies prior to CE marking of flow diverter stents that are implanted to treat intracranial aneurysms.

To View This Article:

Login

Subscribe To The GMP Letter